Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd stock ¥1.04, price ¥9.96, that is 89.6% below the price, quality 49 out of 100. Rating: strongly overvalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
000766 · SHEFar too expensive (fair value 90% below the price) and falling price, but company just good enough: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 21, 2026.
How to read this chart
60‑month range ¥3.71 – ¥29.50 · fair‑value band ¥0.45 – ¥1.66 · the ¥9.96 price screens above the ¥1.04 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 21, 2026.
Every Wednesday you see whether Tonghua Golden-Horse Pharmaceutical Industry Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China.
Show moreShow less
The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications.
It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases.
In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction.
The company was founded in 1990 and is headquartered in Tonghua, China.
Stock analysis
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) currently trades at ¥9.96, while our model-based Fair Value estimate is ¥1.04, 90% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of ¥1.58 per share, and 0 of the 22 models we run sit above the ¥9.96 price.
Bear case: the Earnings-Based group reads lowest at ¥0.58, and 22 of the 22 models stay below the price. Data coverage for this calculation is low.
Scenario range: ¥0.45 (bear) to ¥1.66 (bull), the price of ¥9.96 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd reported revenue of 1.2B CNY in FY2025 versus 1.5B CNY in FY2021, a compound −6.3%/yr. Reported net income was 34.3M CNY in FY2025, compounding −0.7%/yr from FY2021.
Key figures
Market cap 10.0B CNY (≈ $1.5B) Small · P/E ratio 498.0 · P/S ratio 9.84 · EPS (TTM) ¥0.02 · Dividend yield 0.6% · Net margin 1.1% · Return on equity 0.5% · Return on assets (EBIT) 1.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 26 out of 100 (medium confidence).
What moves the price
The share trades about 66% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −26% fair-value upside, at −90%, 000766 screens richer than that median.
Fair Value models
All 25 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
000766 screens overvalued: fair value 90% below the price. Compare with Merck KGaA →
Compare Tonghua Golden-Horse Pharmaceutical Industry Co Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 610 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Revenue growth by industry
- PEG ratio by industry
- Stock screener with 62 metrics
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $79.11 | $113.53 | +44% | vs 000766 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.00 | ¥52.43 | +12% | vs 000766 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,884.90 | ₹1,982.92 | +5% | vs 000766 |
| Haleon plc HLN | $9.07 | $8.47 | −7% | vs 000766 |
| Merck KGaA MRK | €146.45 | €108.83 | −26% | vs 000766 |
| Galderma Group GALD | CHF 182.85 | CHF 112.84 | −38% | vs 000766 |
| Teva Pharmaceutical Industries Limited TEVA | $39.23 | $20.74 | −47% | vs 000766 |
| Takeda Pharmaceutical Company TAK | $21.77 | $11.26 | −48% | vs 000766 |
| Sandoz Group SDZ | CHF 80.50 | CHF 41.06 | −49% | vs 000766 |
| Divi's Laboratories Limited DIVISLAB | ₹11,180.50 | ₹1,566.89 | −86% | vs 000766 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) overvalued or undervalued?
What is the fair value of 000766?
What is the quality score of 000766?
What is the price target for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What is the Tonghua Golden-Horse Pharmaceutical Industry Co Ltd stock forecast for 2026?
What is the revenue of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
Does Tonghua Golden-Horse Pharmaceutical Industry Co Ltd pay a dividend?
How much is the dividend of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What growth is priced into Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What discount rate (WACC) does the fair value of 000766 use?
What is a reverse DCF?
How much growth has Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) delivered so far?
How fast is the sector of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) growing?
What is the free cash flow yield of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What is the intrinsic value of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
Is Tonghua Golden-Horse Pharmaceutical Industry Co Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 000766?
How much is Tonghua Golden-Horse Pharmaceutical Industry Co Ltd worth?
What do the bullish and bearish scenarios say about 000766?
What is the P/E ratio of 000766?
How solid is the balance sheet of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
How far is 000766 from its 52-week high?
Which stocks are comparable to Tonghua Golden-Horse Pharmaceutical Industry Co Ltd?
Is Tonghua Golden-Horse Pharmaceutical Industry Co Ltd stock attractive at the current price?
How is the fair value of 000766 calculated?
Is it still worth investing in stocks now?
What is the share price of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What should I pay attention to with Tonghua Golden-Horse Pharmaceutical Industry Co Ltd right now?
Where does the earnings growth of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) come from?
Key figures of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
How large is the market capitalisation of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What is the P/S ratio of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What are the earnings per share of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What is the dividend yield of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What is the net margin of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What is the return on equity of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What is the EBIT return on assets of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
What is the operating margin of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
How fast is revenue growing at Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
How fast are earnings growing at Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766)?
How much net debt does Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) carry?
Watch Tonghua Golden-Horse Pharmaceutical Industry Co Ltd in the live analysis
One click puts Tonghua Golden-Horse Pharmaceutical Industry Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.